This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 

Contains 286 pages and 28 tables